79 research outputs found
Deciphering the Landscape of Food Science Research Footprints: Scientific Specialties and SDGs
Due to prevailing milieus, combating hunger, malnutrition, and improving functioning of food systems are now of greater priority to national and international policymakers than they were when the United Nations Sustainable Development Goals (UN SDGs) were announced in 2015. The trade-offs between sustainability, food security, food safety, and making better use of food already produced need to be addressed in the right perspective, using a hierarchy of strategies. One of the strategies could be to analyse research output to divulge the momentum research topics in the domain. This article explores core research specialties using the SCOPUS data due to its comprehensive coverage of the research output in food science from India during 2011–2020. The major outcomes reveal that: (a) research specialties of top topic clusters fall in the worldwide momentum areas and primary focus of Indian researchers lies in finding solutions to the aspects of security, safety, sustainability of food, and addressing the crucial aspects of malnutrition, involving an array of topics ranging from application of processes to enhancement of health benefits of plant food for human consumption; (b) prominence indicator signals that the top worldwide momentum areas have potency to attract more funding; (c) co-relation between prominent topic clusters, research topics of top contributing author’s, institutions and in highly cited papers vis a vis SDG’s elucidates that the research topics addressed by researchers, in general, are kindred topic areas, hence of core research importance. The study presents a discussion of the outcomes leading to evidence-based inferences, with enduring impact and value-addition to domain knowledge that can aid several stakeholders
Recommended from our members
Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential
BACKGROUND: In cancer cells, telomerase induction helps maintain telomere length and thereby bypasses senescence and provides enhanced replicative potential. Chemical inhibitors of telomerase have been shown to reactivate telomere shortening and cause replicative senescence and apoptotic cell death of tumor cells while having little or no effect on normal diploid cells. RESULTS: We designed siRNAs against two different regions of telomerase gene and evaluated their effect on telomere length, proliferative potential, and gene expression in Barrett's adenocarcinoma SEG-1 cells. The mixture of siRNAs in nanomolar concentrations caused a loss of telomerase activity that appeared as early as day 1 and was essentially complete at day 3. Inhibition of telomerase activity was associated with marked reduction in median telomere length and complete loss of detectable telomeres in more than 50% of the treated cells. Telomere loss caused senescence in 40% and apoptosis in 86% of the treated cells. These responses appeared to be associated with activation of DNA sensor HR23B and subsequent activation of p53 homolog p73 and p63 and E2F1. Changes in these gene regulators were probably the source of observed up-regulation of cell cycle inhibitors, p16 and GADD45. Elevated transcript levels of FasL, Fas and caspase 8 that activate death receptors and CARD 9 that interacts with Bcl10 and NFKB to enhance mitochondrial translocation and activation of caspase 9 were also observed. CONCLUSION: These studies show that telomerase siRNAs can cause effective suppression of telomerase and telomere shortening leading to both cell cycle arrest and apoptosis via mechanisms that include up-regulation of several genes involved in cell cycle arrest and apoptosis. Telomerase siRNAs may therefore be strong candidates for highly selective therapy for chemoprevention and treatment of Barrett's adenocarcinoma
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.
Purpose T-cell-replete HLA-haploidentical donor hematopoietic transplantation using post-transplant cyclophosphamide was originally described using bone marrow (BM). With increasing use of mobilized peripheral blood (PB), we compared transplant outcomes after PB and BM transplants. Patients and Methods A total of 681 patients with hematologic malignancy who underwent transplantation in the United States between 2009 and 2014 received BM (n = 481) or PB (n = 190) grafts. Cox regression models were built to examine differences in transplant outcomes by graft type, adjusting for patient, disease, and transplant characteristics. Results Hematopoietic recovery was similar after transplantation of BM and PB (28-day neutrophil recovery, 88% v 93%, P = .07; 100-day platelet recovery, 88% v 85%, P = .33). Risks of grade 2 to 4 acute (hazard ratio [HR], 0.45; P \u3c .001) and chronic (HR, 0.35; P \u3c .001) graft-versus-host disease were lower with transplantation of BM compared with PB. There were no significant differences in overall survival by graft type (HR, 0.99; P = .98), with rates of 54% and 57% at 2 years after transplantation of BM and PB, respectively. There were no differences in nonrelapse mortality risks (HR, 0.92; P = .74) but relapse risks were higher after transplantation of BM (HR, 1.49; P = .009). Additional exploration confirmed that the higher relapse risks after transplantation of BM were limited to patients with leukemia (HR, 1.73; P = .002) and not lymphoma (HR, 0.87; P = .64). Conclusion PB and BM grafts are suitable for haploidentical transplantation with the post-transplant cyclophosphamide approach but with differing patterns of treatment failure. Although, to our knowledge, this is the most comprehensive comparison, these findings must be validated in a randomized prospective comparison with adequate follow-up
Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells
The induction of interferon beta (IFNB1) is a key event in the antiviral immune response. We studied the role of transcriptional noise in the regulation of the IFNB1 locus in primary cultures of human dendritic cells (DCs), which are important ‘first responders’ to viral infection. In single cell assays, IFNB1 mRNA expression in virus-infected DCs showed much greater cell-to-cell variation than that of a housekeeping gene, another induced transcript and viral RNA. We determined the contribution of intrinsic noise by measuring the allelic origin of transcripts in each cell and found that intrinsic noise is a very significant part of total noise. We developed a stochastic model to investigate the underlying mechanisms. We propose that the surprisingly high levels of IFNB1 transcript noise originate from the complexity of IFNB1 enhanceosome formation, which leads to a range up to many minutes in the differences within each cell in the time of activation of each allele
Advances in understanding ischemic acute kidney injury
Acute kidney injury (AKI) is independently associated with increased morbidity and mortality. Ischemia is the leading cause of AKI, and short of supportive measures, no currently available therapy can effectively treat or prevent ischemic AKI. This paper discusses recent developments in the understanding of ischemic AKI pathophysiology, the emerging relationship between ischemic AKI and development of progressive chronic kidney disease, and promising novel therapies currently under investigation. On the basis of recent breakthroughs in understanding the pathophysiology of ischemic AKI, therapies that can treat or even prevent ischemic AKI may become a reality in the near future
Enhancing apoptosis in TRAIL-resistant cancer cells using fundamental response rules
The tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induces apoptosis
in malignant cells, while leaving other cells mostly unharmed. However, several
carcinomas remain resistant to TRAIL. To investigate the resistance mechanisms in
TRAIL-stimulated human fibrosarcoma (HT1080) cells, we developed a computational
model to analyze the temporal activation profiles of cell survival (IκB, JNK, p38)
and apoptotic (caspase-8 and -3) molecules in wildtype and several (FADD, RIP1,
TRAF2 and caspase-8) knock-down conditions. Based on perturbation-response approach
utilizing the law of information (signaling flux) conservation, we derived response
rules for population-level average cell response. From this approach, i) a
FADD-independent pathway to activate p38 and JNK, ii) a crosstalk between RIP1 and
p38, and iii) a crosstalk between p62 and JNK are predicted. Notably, subsequent
simulations suggest that targeting a novel molecule at p62/sequestosome-1 junction
will optimize apoptosis through signaling flux redistribution. This study
offers a valuable prospective to sensitive TRAIL-based therapy
Nanosized TiO2: a promising catalyst for the aldol condensation of furfural with acetone in biomass upgrading
Nanosized TiO2catalyst was successfully prepared by a simple green procedure and used in liquid phasealdol condensation of furfural with acetone, a key step in bio-fuel processing. In order to determinethe effect of calcination temperature on catalytic properties of TiO2, the as-prepared TiO2and calcinedTiO2(150–900◦C) were studied by XRD, BET, TPD-CO2/NH3, TGA/DTG and FTIR evaluation. The catalyticperformance of TiO2samples in aldol condensation of furfural with acetone was evaluated and comparedwith that of Mg–Al hydrotalcites and a BEA zeolite. These experiments showed that uncalcined TiO2possessed reasonable activity in aldol condensation of furfural to acetone and resulted in commonlyproduced condensation products. The observed catalytic behavior of TiO2could be competitive withthat reported for other inorganic solids. The calcination of TiO2resulted, however, in a decrease in itscatalytic activity due to extensive dehydration and surface dehydroxylation as well as due to changes oftextural properties resulting in a decrease in the amount of accessible active sites. Thanks to its advancedproperties, nanosized TiO2is a promising catalyst for aldol condensation of furfural with acetone andcould broaden possibilities for optimizing conditions for bio-fuel production
Recommended from our members
Universal DNA methylation age across mammalian tissues.
Aging, often considered a result of random cellular damage, can be accurately estimated using DNA methylation profiles, the foundation of pan-tissue epigenetic clocks. Here, we demonstrate the development of universal pan-mammalian clocks, using 11,754 methylation arrays from our Mammalian Methylation Consortium, which encompass 59 tissue types across 185 mammalian species. These predictive models estimate mammalian tissue age with high accuracy (r > 0.96). Age deviations correlate with human mortality risk, mouse somatotropic axis mutations and caloric restriction. We identified specific cytosines with methylation levels that change with age across numerous species. These sites, highly enriched in polycomb repressive complex 2-binding locations, are near genes implicated in mammalian development, cancer, obesity and longevity. Our findings offer new evidence suggesting that aging is evolutionarily conserved and intertwined with developmental processes across all mammals
Universal DNA methylation age across mammalian tissues
Aging, often considered a result of random cellular damage, can be accurately estimated using DNA methylation profiles, the foundation of pan-tissue epigenetic clocks. Here, we demonstrate the development of universal pan-mammalian clocks, using 11,754 methylation arrays from our Mammalian Methylation Consortium, which encompass 59 tissue types across 185 mammalian species. These predictive models estimate mammalian tissue age with high accuracy (r > 0.96). Age deviations correlate with human mortality risk, mouse somatotropic axis mutations and caloric restriction. We identified specific cytosines with methylation levels that change with age across numerous species. These sites, highly enriched in polycomb repressive complex 2-binding locations, are near genes implicated in mammalian development, cancer, obesity and longevity. Our findings offer new evidence suggesting that aging is evolutionarily conserved and intertwined with developmental processes across all mammals.Publisher PDFPeer reviewe
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
Background: Intensive antiplatelet therapy with three agents might be more effective than guideline treatment for preventing recurrent events in patients with acute cerebral ischaemia. We aimed to compare the safety and efficacy of intensive antiplatelet therapy (combined aspirin, clopidogrel, and dipyridamole) with that of guideline-based antiplatelet therapy.
Methods: We did an international, prospective, randomised, open-label, blinded-endpoint trial in adult participants with ischaemic stroke or transient ischaemic attack (TIA) within 48 h of onset. Participants were assigned in a 1:1 ratio using computer randomisation to receive loading doses and then 30 days of intensive antiplatelet therapy (combined aspirin 75 mg, clopidogrel 75 mg, and dipyridamole 200 mg twice daily) or guideline-based therapy (comprising either clopidogrel alone or combined aspirin and dipyridamole). Randomisation was stratified by country and index event, and minimised with prognostic baseline factors, medication use, time to randomisation, stroke-related factors, and thrombolysis. The ordinal primary outcome was the combined incidence and severity of any recurrent stroke (ischaemic or haemorrhagic; assessed using the modified Rankin Scale) or TIA within 90 days, as assessed by central telephone follow-up with masking to treatment assignment, and analysed by intention to treat. This trial is registered with the ISRCTN registry, number ISRCTN47823388.
Findings: 3096 participants (1556 in the intensive antiplatelet therapy group, 1540 in the guideline antiplatelet therapy group) were recruited from 106 hospitals in four countries between April 7, 2009, and March 18, 2016. The trial was stopped early on the recommendation of the data monitoring committee. The incidence and severity of recurrent stroke or TIA did not differ between intensive and guideline therapy (93 [6%] participants vs 105 [7%]; adjusted common odds ratio [cOR] 0·90, 95% CI 0·67–1·20, p=0·47). By contrast, intensive antiplatelet therapy was associated with more, and more severe, bleeding (adjusted cOR 2·54, 95% CI 2·05–3·16, p<0·0001).
Interpretation: Among patients with recent cerebral ischaemia, intensive antiplatelet therapy did not reduce the incidence and severity of recurrent stroke or TIA, but did significantly increase the risk of major bleeding. Triple antiplatelet therapy should not be used in routine clinical practice
- …